GV.PA
Price:
$0.0018
Market Cap:
$693.19K
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutio...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2014-04-02
Stock Exchange
EURONEXT
Ticker
GV.PA
According to Genomic Vision Société Anonyme’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -94.94% compared to the average of -0.32 of the last 4 quarters.
The mean historical PE Ratio of Genomic Vision Société Anonyme over the last ten years is -8.07. The current -0.02 PE Ratio has changed -79.73% with respect to the historical average. Over the past ten years (40 quarters), GV.PA's PE Ratio was at its highest in in the December 2019 quarter at 0. The PE Ratio was at its lowest in in the January 2013 quarter at -34.89.
Average
-8.07
Median
-2.32
Minimum
-34.89
Maximum
-0.39
Discovering the peaks and valleys of Genomic Vision Société Anonyme PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 361.20%
Maximum Annual PE Ratio = -0.39
Minimum Annual Increase = -78.35%
Minimum Annual PE Ratio = -34.89
Year | PE Ratio | Change |
---|---|---|
2022 | -0.73 | -68.58% |
2021 | -2.31 | -63.79% |
2020 | -6.39 | 256.26% |
2019 | -1.79 | 361.20% |
2018 | -0.39 | -78.35% |
2017 | -1.80 | -22.54% |
2016 | -2.32 | -74.29% |
2015 | -9.02 | -57.29% |
2014 | -21.11 | -39.49% |
The current PE Ratio of Genomic Vision Société Anonyme (GV.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.14
5-year avg
-2.32
10-year avg
-8.07
Genomic Vision Société Anonyme’s PE Ratio is greater than Biophytis S.A. (-0.05), greater than Novacyt S.A. (-1.81), less than Hybrigenics SA (2.26), less than Visiomed Group SA (56.30), greater than Biosynex SA (-1.30),
Company | PE Ratio | Market cap |
---|---|---|
-0.05 | $2.60M | |
-1.81 | $69.50M | |
2.26 | $3.95M | |
56.30 | $52.99M | |
-1.30 | $47.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomic Vision Société Anonyme using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomic Vision Société Anonyme or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genomic Vision Société Anonyme's PE Ratio?
How is the PE Ratio calculated for Genomic Vision Société Anonyme (GV.PA)?
What is the highest PE Ratio for Genomic Vision Société Anonyme (GV.PA)?
What is the 3-year average PE Ratio for Genomic Vision Société Anonyme (GV.PA)?
What is the 5-year average PE Ratio for Genomic Vision Société Anonyme (GV.PA)?
How does the current PE Ratio for Genomic Vision Société Anonyme (GV.PA) compare to its historical average?